Viva Biotech Announces 2025 Annual Results: AI-Driven Drug Discovery Reinforces Industry Leadership, CDMO Commercial Products Enter Rapid Scale-Up
PR Newswire —
Financial Highlights Revenue reached RMB1,729.4 million Gross profit amounted to RMB655.6 million Gross profit margin recorded 37.9%, a YOY increase of 3.3 pp Net profit recorded RMB269.3 million, a YOY increase 21.3% Adjusted non-IFRS net profit recorded RMB335.3 million, a YOY increase...